scholarly article | Q13442814 |
P356 | DOI | 10.1016/0022-1759(92)90112-7 |
P953 | full work available at URL | https://api.elsevier.com/content/article/PII:0022175992901127?httpAccept=text/xml |
https://api.elsevier.com/content/article/PII:0022175992901127?httpAccept=text/plain | ||
P698 | PubMed publication ID | 1321199 |
P50 | author | Steven Rosenberg | Q2347448 |
P2093 | author name string | C. A. Smith | |
S. A. Rosenberg | |||
S. Schwarz | |||
J. J. Mulé | |||
M. Custer | |||
P. Hwu | |||
P2860 | cites work | Molecular cloning and expression of a receptor for human tumor necrosis factor | Q24303604 |
An endotoxin-induced serum factor that causes necrosis of tumors | Q24564406 | ||
Improved retroviral vectors for gene transfer and expression | Q29614384 | ||
Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism | Q33450431 | ||
A phase I trial of intravenously-administered recombinant tumor necrosis factor-alpha in cancer patients | Q33451539 | ||
A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins | Q33909940 | ||
Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction | Q34354588 | ||
Partial purification of a serum factor that causes necrosis of tumors | Q35984071 | ||
Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes | Q36230021 | ||
Intralesional application of recombinant human tumor necrosis factor alpha induces local tumor regression in patients with advanced malignancies | Q40778483 | ||
Phase I study of recombinant human tumor necrosis factor alpha in advanced malignant disease | Q40779573 | ||
Recombinant Human Tumor Necrosis Factor Administered as a 24-Hour Intravenous Infusion. A Phase I and Pharmacologic Study | Q40783265 | ||
Optimal collection of blood samples for the measurement of tumor necrosis factor alpha | Q41723874 | ||
Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials | Q44098509 | ||
Molecular cloning of the complementary DNA for human tumor necrosis factor | Q48379825 | ||
EVIDENCE FOR TUMOUR NECROSIS FACTOR/CACHECTIN PRODUCTION IN CANCER | Q61819299 | ||
Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma | Q69484555 | ||
Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients | Q69548004 | ||
Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo | Q69727000 | ||
Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice | Q70589154 | ||
P433 | issue | 1-2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | TNF | Q18032037 |
immunology | Q101929 | ||
P304 | page(s) | 139-147 | |
P577 | publication date | 1992-07-01 | |
1992-07-06 | |||
P1433 | published in | Journal of Immunological Methods | Q15755939 |
P1476 | title | Use of soluble recombinant TNF receptor to improve detection of TNF secretion in cultures of tumor infiltrating lymphocytes | |
P478 | volume | 151 |
Search more.